By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cellzome AG 

Meyerhofstrasse 1

Heidelberg    69117  Germany
Phone: 49-6221-137-57-0 Fax: 49-6221-137-57-201


Company News
GlaxoSmithKline (GSK) to Fully Buy Cellzome AG for $99 Million 5/15/2012 7:48:56 AM
Cellzome AG Awarded UK's Technology Strategy Board Grant as Part of the Regenerative Medicine Program 12/6/2011 9:06:40 AM
Cellzome AG Founder Wins EU Women Innovators Award 12/6/2011 9:04:15 AM
Cellzome AG Proteomic Study Published in the Journal Nature Paves the Way for New Treatment for Incurable Leukaemia Using an Epigenetic Inhibitor 10/3/2011 11:59:22 AM
Cellzome AG Achieves Clinical Candidate Milestone from Inflammation Alliance with GlaxoSmithKline (GSK) 9/14/2011 10:30:34 AM
Cellzome AG to Study Epigenetic Factors with Neusentis 5/10/2011 11:06:06 AM
Cellzome AG Builds Scientific Advisory Board with World-Leading Experts in Proteomics, Epigenetics and Immunology 2/23/2011 9:53:33 AM
Cellzome AG Announces Achievement of Second Milestone in Epigenetics Collaboration with GlaxoSmithKline (GSK) 2/8/2011 9:48:32 AM
Asterand plc (ATD.L)’s Subsidiary BioSeek Signs Agreement with Cellzome AG 9/23/2010 11:12:48 AM
Cellzome AG Technology Used to Unravel Novel Regulatory Mechanism in Cancer Signaling Pathway 9/17/2009 10:07:41 AM